U.S. markets open in 4 hours 46 minutes

Cocrystal Pharma, Inc. (COCP)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.4000-0.0700 (-4.76%)
At close: 4:00PM EDT

1.4100 +0.01 (0.71%)
Pre-Market: 4:35AM EDT

Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
As of Date: 5/6/2021
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 7

Trading Information

Stock Price History

Beta (5Y Monthly) 0.74
52-Week Change 356.38%
S&P500 52-Week Change 342.25%
52 Week High 33.4600
52 Week Low 30.7600
50-Day Moving Average 31.3588
200-Day Moving Average 31.4462

Share Statistics

Avg Vol (3 month) 313.65M
Avg Vol (10 day) 3107.76M
Shares Outstanding 571.47M
Implied Shares Outstanding 6N/A
Float 51.21M
% Held by Insiders 127.86%
% Held by Institutions 114.23%
Shares Short (Apr 14, 2021) 42.12M
Short Ratio (Apr 14, 2021) 41.77
Short % of Float (Apr 14, 2021) 43.96%
Short % of Shares Outstanding (Apr 14, 2021) 42.97%
Shares Short (prior month Mar 14, 2021) 42.26M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jan 23, 2018
Ex-Dividend Date 4N/A
Last Split Factor 21:30
Last Split Date 3Jan 23, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020


Profit Margin 0.00%
Operating Margin (ttm)-475.97%

Management Effectiveness

Return on Assets (ttm)-14.48%
Return on Equity (ttm)-24.67%

Income Statement

Revenue (ttm)2.01M
Revenue Per Share (ttm)0.04
Quarterly Revenue Growth (yoy)26.90%
Gross Profit (ttm)-4.29M
Net Income Avi to Common (ttm)-9.65M
Diluted EPS (ttm)-0.1750
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)33.01M
Total Cash Per Share (mrq)0.46
Total Debt (mrq)596k
Total Debt/Equity (mrq)1.13
Current Ratio (mrq)25.05
Book Value Per Share (mrq)0.75

Cash Flow Statement

Operating Cash Flow (ttm)-9.83M
Levered Free Cash Flow (ttm)-6.25M